Merck Shares Outstanding 2012-2025 | MKKGY

Merck shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Merck shares outstanding for the quarter ending September 30, 2025 were 2.179B, a 0.17% increase year-over-year.
Merck 2024 shares outstanding were 2.174B, a 0.08% decline from 2023.
Merck 2023 shares outstanding were 2.176B, a 0.08% increase from 2022.
Merck 2022 shares outstanding were 2.174B, a 0% decline from 2021.

Merck Annual Shares Outstanding (Millions of Shares)
2024	2,174
2023	2,176
2022	2,174
2021	2,174
2020	2,174
2019	2,174
2018	2,174
2017	2,174
2016	2,174
2015	2,174
2014	2,175
2013	2,174
2012	2,174
2011	2,174

Merck Quarterly Shares Outstanding (Millions of Shares)
2025-09-30	2,179
2025-06-30	2,174
2025-03-31	2,175
2024-12-31	2,174
2024-09-30	2,175
2024-06-30	2,174
2024-03-31	2,169
2023-12-31	2,176
2023-09-30	2,174
2023-06-30	2,173
2023-03-31	2,175
2022-12-31	2,174
2022-09-30	2,177
2022-06-30	2,174
2022-03-31	2,178
2021-12-31	2,174
2021-09-30	2,174
2021-06-30	2,174
2021-03-31	2,172
2020-12-31	2,174
2020-09-30	2,176
2020-06-30	2,164
2020-03-31	2,172
2019-12-31	2,174
2019-09-30	2,171
2019-06-30	2,174
2019-03-31	2,198
2018-12-31	2,174
2018-09-30	2,179
2018-06-30	2,167
2018-03-31	2,186
2017-12-31	2,174
2017-09-30	2,179
2017-06-30	2,170
2017-03-31	2,171
2016-12-31	2,174
2016-09-30	2,176
2016-06-30	2,167
2016-03-31	2,173
2015-12-31	2,167
2015-09-30	2,167
2015-06-30	2,173
2015-03-31	2,174
2014-12-31	2,188
2014-09-30	2,189
2014-06-30	2,174
2014-03-31	1,084
2013-12-31	2,175
2013-09-30	2,177
2013-06-30	2,174
2013-03-31	2,174
2012-12-31	2,174
2012-09-30	2,182
2012-06-30	2,174
2012-03-31	2,174
2011-12-31	2,174
2011-09-30	2,174
2011-06-30	2,174
2011-03-31	2,174

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$19.005B	$22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$84.909B	32.25
Zoetis (ZTS)	United States	$54.311B	19.44
Takeda Pharmaceutical (TAK)	Japan	$51.389B	10.49
Daiichi Sankyo, - (DSNKY)	Japan	$38.891B	19.37
BeOne Medicines - (ONC)	Switzerland	$36.658B	194.35
Sandoz Group AG (SDZNY)	Switzerland	$33.832B	0.00
United Therapeutics (UTHR)	United States	$20.154B	17.74
Shionogi (SGIOY)	Japan	$15.636B	14.36
Neurocrine Biosciences (NBIX)	United States	$13.414B	32.19
IPSEN (IPSEY)	France	$12.891B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.558B	0.00
Summit Therapeutics (SMMT)	United States	$12.385B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.468B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.120B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$5.940B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.784B	32.37
Crinetics Pharmaceuticals (CRNX)	United States	$5.285B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.190B	19.90
Indivior (INDV)	United States	$4.119B	16.81
Corcept Therapeutics (CORT)	United States	$3.712B	40.10
NewAmsterdam Pharma (NAMS)	Netherlands	$3.675B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.081B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.874B	9.17
Hypermarcas (HYPMY)	Brazil	$2.755B	18.91
Ocular Therapeutix (OCUL)	United States	$2.439B	0.00
Dyne Therapeutics (DYN)	United States	$2.368B	0.00
Soleno Therapeutics (SLNO)	United States	$2.349B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.950B	23.11
Ardelyx (ARDX)	United States	$1.885B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.818B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.793B	34.54
Harrow (HROW)	United States	$1.767B	108.46
Oruka Therapeutics (ORKA)	United States	$1.609B	0.00
Enliven Therapeutics (ELVN)	United States	$1.605B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.508B	7.46
BioCryst Pharmaceuticals (BCRX)	United States	$1.406B	83.38
Relay Therapeutics (RLAY)	United States	$1.284B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.263B	0.00
Savara (SVRA)	United States	$1.215B	0.00
Evotec AG (EVO)	Germany	$1.204B	0.00
Theravance Biopharma (TBPH)	United States	$1.035B	43.45
ARS Pharmaceuticals (SPRY)	United States	$1.033B	0.00
Cronos Group (CRON)	Canada	$0.973B	0.00
Aktis Oncology (AKTS)	United States	$0.951B	0.00
Xencor (XNCR)	United States	$0.903B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.774B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.745B	17.61
Nektar Therapeutics (NKTR)	United States	$0.737B	0.00
Esperion Therapeutics (ESPR)	United States	$0.691B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.660B	5.89
ProKidney (PROK)	United States	$0.644B	0.00
Bioventus (BVS)	United States	$0.638B	13.07
Lexeo Therapeutics (LXEO)	United States	$0.530B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.508B	0.00
Lyell Immunopharma (LYEL)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.505B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.480B	0.00
Organogenesis (ORGO)	United States	$0.471B	0.00
Siga Technologies (SIGA)	United States	$0.468B	6.41
Altimmune (ALT)	United States	$0.441B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.435B	0.00
Aquestive Therapeutics (AQST)	United States	$0.425B	0.00
Nature's Sunshine Products (NATR)	United States	$0.418B	24.91
USANA Health Sciences (USNA)	United States	$0.402B	11.21
Cybin (HELP)	Canada	$0.383B	0.00
Akebia Therapeutics (AKBA)	United States	$0.356B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.292B	0.00
Protara Therapeutics (TARA)	United States	$0.289B	0.00
Relmada Therapeutics (RLMD)	United States	$0.289B	0.00
Profound Medical (PROF)	Canada	$0.286B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.286B	0.00
Avalo Therapeutics (AVTX)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Larimar Therapeutics (LRMR)	United States	$0.265B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Heron Therapeutics (HRTX)	United States	$0.260B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.246B	0.00
Journey Medical (DERM)	United States	$0.237B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.233B	0.00
MediWound (MDWD)	Israel	$0.218B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.207B	0.00
Galectin Therapeutics (GALT)	United States	$0.193B	0.00
Minerva Neurosciences (NERV)	United States	$0.189B	0.00
AleAnna (ANNA)	United States	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.168B	0.00
VAXART, INC (VXRT)	United States	$0.166B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Surrozen (SRZN)	United States	$0.154B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.151B	0.00
Context Therapeutics (CNTX)	United States	$0.141B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.141B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.124B	0.00
Incannex Healthcare (IXHL)	Australia	$0.124B	0.00
Prelude Therapeutics (PRLD)	United States	$0.116B	0.00
Avita Medical (RCEL)	United States	$0.115B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.109B	0.00
Pyxis Oncology (PYXS)	United States	$0.103B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.101B	0.00
Vivani Medical (VANI)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.097B	41.18
Cassava Sciences (SAVA)	United States	$0.096B	0.00
Korro Bio (KRRO)	United States	$0.081B	0.00
Gain Therapeutics (GANX)	United States	$0.077B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
PolyPid (PYPD)	Israel	$0.071B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.00
Dominari Holdings (DOMH)	United States	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.064B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.060B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.056B	0.00
Lipocine (LPCN)	United States	$0.055B	0.00
ElectroCore (ECOR)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.046B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.035B	0.00
Wellgistics Health (WGRX)	United States	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.031B	0.00
Natural Alternatives (NAII)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.023B	0.00
Traws Pharma (TRAW)	United States	$0.021B	0.03
Scienture Holdings (SCNX)	United States	$0.020B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00